Effect of selenium compounds and thiols on human mammary tumor cells
- PMID: 1723886
- DOI: 10.1007/BF02990350
Effect of selenium compounds and thiols on human mammary tumor cells
Abstract
The effect on cell viability and growth rate of sodium selenite, selenocystine, sodium selenate, and selenomethionine at selenium concentrations of 6.25 and 12.5 uM was studied in vitro on cells of the human mammary tumor cell line HTB123/DU4475. Selenite and selenocystine affected both cell viability and growth rate of the tumor cells at these selenium concentrations. Selenite and selenocystine decreased intracellular glutathione concentrations, but did not affect tumor cell glutathione peroxidase activity. After six days of exposure to either selenate or selenomethionine, the viability of tumor cells remained stable, but cell growth, as measured by numbers of cells, was retarded. Neither selenate nor selenomethionine produced changes in concentrations of intracellular glutathione. The toxic effect of selenite on tumor cells was enhanced by addition of 0.25 mM glutathione to the growth medium. Preincubation of the tumor cells with 62.5 uM buthionine sulfoximine decreased cellular glutathione to 15% of controls at 24 h and enhanced the toxicity of selenite toward the tumor cells. Glutathione, 2-mercaptoethanol, and L-cysteine were all toxic to the tumor cells in a dose-dependent manner.
Similar articles
-
Generation of reactive oxygen species from the reaction of selenium compounds with thiols and mammary tumor cells.Biochem Pharmacol. 1993 Jan 26;45(2):429-37. Biochem Pharmacol. 1993. PMID: 8382065
-
Inhibition of cell colony formation by selenite: involvement of glutathione.Mol Pharmacol. 1991 Mar;39(3):281-4. Mol Pharmacol. 1991. PMID: 1826039
-
Products of the reaction of selenite with intracellular sulfhydryl compounds.Biol Trace Elem Res. 1991 Jul;30(1):9-18. doi: 10.1007/BF02990338. Biol Trace Elem Res. 1991. PMID: 1718373
-
Antitumor Effects of Selenium.Int J Mol Sci. 2021 Oct 31;22(21):11844. doi: 10.3390/ijms222111844. Int J Mol Sci. 2021. PMID: 34769276 Free PMC article. Review.
-
Immunomodulatory and Anti-Inflammatory Properties of Selenium-Containing Agents: Their Role in the Regulation of Defense Mechanisms against COVID-19.Int J Mol Sci. 2022 Feb 21;23(4):2360. doi: 10.3390/ijms23042360. Int J Mol Sci. 2022. PMID: 35216476 Free PMC article. Review.
Cited by
-
A Rapid Dual-Responsive Releasing Nano-Carrier by Decomposing the Copolymer and Reversing the Core Dissolution.Front Bioeng Biotechnol. 2021 Nov 4;9:784838. doi: 10.3389/fbioe.2021.784838. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 34805131 Free PMC article.
-
Effect of selenium compounds on murine B16 melanoma cells and pigmented cloned pB16 cells.Arch Toxicol. 1994;68(4):246-54. doi: 10.1007/s002040050064. Arch Toxicol. 1994. PMID: 8067897
-
Responses of an American eel brain endothelial-like cell line to selenium deprivation and to selenite, selenate, and selenomethionine additions in different exposure media.In Vitro Cell Dev Biol Anim. 2017 Dec;53(10):940-953. doi: 10.1007/s11626-017-0196-4. Epub 2017 Sep 22. In Vitro Cell Dev Biol Anim. 2017. PMID: 28940125
-
Investigating the Potential of Conjugated Selenium Redox Folic Acid as a Treatment for Triple Negative Breast Cancer.Antioxidants (Basel). 2020 Feb 5;9(2):138. doi: 10.3390/antiox9020138. Antioxidants (Basel). 2020. PMID: 32033374 Free PMC article.
-
Cytotoxicity of Selenium Immunoconjugates against Triple Negative Breast Cancer Cells.Int J Mol Sci. 2018 Oct 26;19(11):3352. doi: 10.3390/ijms19113352. Int J Mol Sci. 2018. PMID: 30373175 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical